BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
JCI - Applying the discovery of the Philadelphia chromosome
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
Bcr-Abl阻害 | Bcr-Abl Inhibition
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
